Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00046449 · ClinicalTrials.gov registry record · Phase 3
Prevention of Seasonal Affective Disorder
A Phase 3 study, sponsored by GlaxoSmithKline.
- Completed
- Registry status
- Phase 3
- Development phase
NCT00046449: Completed Phase 3 study, sponsored by GlaxoSmithKline.
NCT00046449 is a Phase 3 study that has completed, run by GlaxoSmithKline. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00046449, a Phase 3 study, has completed, sponsored by GlaxoSmithKline.
- COMPLETED
- Registry status
- Phase 3
- Development phase
Study Summary
A Placebo Controlled Study Evaluating The Effectivess Of Medication In Preventing Seasonal Affective Disorder
Interventions
- DRUG Investigational Seasonal Affective Disorder (SAD) Drug
Trial Details
| Field | Value |
|---|---|
| Start Date | 2002-09 |
| Est. Completion | 2003-06 |
| Phase | Phase 3 |
What the finished NCT00046449 record still lists
NCT00046449 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 1 intervention - of which Investigational Seasonal Affective Disorder (SAD) Drug is the first listed.
NCT00046449 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00046449 about?
NCT00046449 is a clinical study titled "Prevention of Seasonal Affective Disorder". A Placebo Controlled Study Evaluating The Effectivess Of Medication In Preventing Seasonal Affective Disorder
What is the current status of trial NCT00046449?
This trial is currently completed. It is a Phase 3 study. The study started on 2002-09. Estimated completion is 2003-06.
What interventions are being tested in trial NCT00046449?
The interventions under investigation include: Investigational Seasonal Affective Disorder (SAD) Drug (DRUG).
Who is sponsoring clinical trial NCT00046449?
This trial is sponsored by GlaxoSmithKline, which has 1,345 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia